| Code | Description | Claims | Beneficiaries | Total Paid |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,615 |
6,195 |
$341K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,167 |
6,709 |
$284K |
| S8301 |
Infection control supplies, not otherwise specified |
10,977 |
7,964 |
$183K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,729 |
2,250 |
$121K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
9,170 |
3,953 |
$97K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,322 |
4,579 |
$57K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
649 |
616 |
$43K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
570 |
533 |
$35K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
576 |
544 |
$26K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
414 |
379 |
$26K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,147 |
996 |
$23K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,384 |
3,737 |
$22K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,079 |
809 |
$22K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
239 |
222 |
$16K |
| 99383 |
|
218 |
206 |
$15K |
| 99382 |
|
180 |
177 |
$14K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,294 |
934 |
$12K |
| 87807 |
|
1,415 |
1,213 |
$12K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
169 |
159 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
989 |
814 |
$10K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,113 |
977 |
$7K |
| 99381 |
|
46 |
46 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
208 |
193 |
$3K |
| 99384 |
|
24 |
23 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
39 |
39 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
161 |
67 |
$2K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
174 |
162 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
116 |
109 |
$1K |
| 90461 |
|
261 |
208 |
$1K |
| 99000 |
|
157 |
143 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
34 |
34 |
$1K |
| 99441 |
|
62 |
52 |
$1K |
| 97802 |
|
614 |
593 |
$1K |
| 92567 |
|
102 |
97 |
$1K |
| 87400 |
|
116 |
54 |
$1K |
| 99429 |
|
51 |
50 |
$785.68 |
| 83655 |
|
98 |
95 |
$774.94 |
| 81000 |
|
237 |
215 |
$601.47 |
| 99050 |
|
44 |
42 |
$582.74 |
| 92551 |
|
188 |
181 |
$473.86 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
601 |
530 |
$433.88 |
| 99442 |
|
16 |
13 |
$405.79 |
| 96160 |
|
257 |
249 |
$338.04 |
| 92552 |
|
96 |
95 |
$201.84 |
| 87420 |
|
21 |
21 |
$166.43 |
| 87430 |
|
16 |
15 |
$153.92 |
| 85027 |
|
27 |
23 |
$102.63 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
302 |
267 |
$33.20 |
| 81002 |
|
14 |
12 |
$28.92 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
133 |
124 |
$3.35 |
| G9716 |
Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason |
407 |
396 |
$0.04 |
| 90686 |
|
28 |
28 |
$0.01 |
| 99051 |
|
1,149 |
985 |
$0.00 |
| 90734 |
|
38 |
38 |
$0.00 |
| 90670 |
|
345 |
325 |
$0.00 |
| G0271 |
Medical nutrition therapy, reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease), group (2 or more individuals), each 30 minutes |
148 |
146 |
$0.00 |
| 90710 |
|
73 |
72 |
$0.00 |
| 90648 |
|
77 |
75 |
$0.00 |
| 99173 |
|
106 |
105 |
$0.00 |
| 90633 |
|
80 |
78 |
$0.00 |
| 99401 |
|
821 |
634 |
$0.00 |
| 90715 |
|
21 |
21 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
487 |
470 |
$0.00 |
| S9451 |
Exercise classes, non-physician provider, per session |
344 |
335 |
$0.00 |
| 90647 |
|
135 |
128 |
$0.00 |
| 90696 |
|
48 |
45 |
$0.00 |
| 90680 |
|
108 |
99 |
$0.00 |
| 99172 |
|
149 |
143 |
$0.00 |
| 90651 |
|
21 |
21 |
$0.00 |
| 90723 |
|
63 |
61 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
23 |
15 |
$0.00 |